Genentech INC. And ORS. Vs. DGCI And ORS

After Biocon and Mylan, Reliance Life Sciences has approached the Delhi High Court to appeal against an earlier order that imposed marketing restrictions to its copy of Swiss biotech giant Roche's breast cancer drug, Herclon (trastuzumab)